Galvanize Therapeutics

Galvanize Therapeutics is a medical device company specializing in Pulsed Electric Field (PEF) energy-based systems for therapeutic interventions. Following the 2023 merger of Gala Therapeutics, Galvanize Therapeutics, and Galaxy Medical, the company now operates the Aliya® PEF System platform. The company develops disease-modifying bronchoscopic and interventional therapies targeting chronic bronchitis, non-small cell lung cancer, metastatic solid tumors, and cardiac arrhythmias. The Aliya® system utilizes non-thermal pulsed electric fields to ablate tissue and modulate biologic processes, with recent clinical data demonstrating local tumor control and potential immune response induction in lung cancer patients. The company also previously developed the RheOx™ Bronchial Rheoplasty System for reducing mucus-producing cells in chronic bronchitis. Galvanize serves interventional pulmonologists, thoracic surgeons, and oncologists, with focus on minimally invasive, energy-based therapeutic delivery.